Diploma (DPLM) Receives Add Rating from Peel Hunt

Share on StockTwits

Peel Hunt reaffirmed their add rating on shares of Diploma (LON:DPLM) in a research report sent to investors on Monday.

Several other analysts also recently weighed in on the stock. Barclays boosted their target price on shares of Diploma from GBX 1,190 ($15.55) to GBX 1,225 ($16.01) and gave the stock an equal weight rating in a research report on Tuesday, November 20th. Royal Bank of Canada reissued a sector performer rating and set a GBX 1,280 ($16.73) target price on shares of Diploma in a research report on Monday, November 19th. Finally, Berenberg Bank dropped their target price on shares of Diploma from GBX 1,435 ($18.75) to GBX 1,350 ($17.64) and set a hold rating on the stock in a research report on Tuesday, January 29th. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Diploma presently has an average rating of Hold and an average price target of GBX 1,356.43 ($17.72).

LON:DPLM opened at GBX 1,324.74 ($17.31) on Monday. Diploma has a twelve month low of GBX 1,010 ($13.20) and a twelve month high of GBX 1,270 ($16.59).

Diploma (LON:DPLM) last released its earnings results on Monday, November 19th. The company reported GBX 56.40 ($0.74) earnings per share for the quarter, topping the consensus estimate of GBX 55.20 ($0.72) by GBX 1.20 ($0.02).

The business also recently announced a dividend, which was paid on Wednesday, January 23rd. Shareholders of record on Thursday, November 29th were given a dividend of GBX 17.80 ($0.23) per share. This represents a yield of 1.32%. The ex-dividend date was Thursday, November 29th. This is an increase from Diploma’s previous dividend of $7.70.

In other news, insider Nigel Lingwood sold 115,723 shares of the company’s stock in a transaction on Tuesday, January 29th. The shares were sold at an average price of GBX 1,261 ($16.48), for a total value of £1,459,267.03 ($1,906,790.84).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Featured Article: What are retained earnings?

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.